IESE (España)
-
The Agnellis and the Fiat Group: The Story of a Family Empire (B)
Toninato F.; Tàpies, JosepCase DG-1476-EStrategySupplements the (A) case.Starting at €5.74
-
The Agnellis and the Fiat Group: The Story of a Family Empire (C)
Toninato F.; Tàpies, JosepCase DG-1477-EStrategySupplements the (B) case.Starting at €5.74
-
The Captor Opportunity (A)
Valentí Vidal, Albert; González Rodríguez, Jorge; Reutskaja Pastushkova, Elena; Mendoza, ErnestCase M-1397-EMarketingCarbon Purity (CP) acquired Captor Materials S.L. (CM). The main asset of Captor Materials was a patented technology for the removal of nitrogen oxides (NOx). Accumulated exposure to NOx causes gradual health deterioration in employees exposed to these gases. The new Captor technology, which helps remove these NOx, is extremely valuable and can be implemented in a number of sectors where NOx are to be removed from gases. CP identified several mar...Starting at €8.20
-
Los Agnelli y el Grupo Fiat: La historia de un imperio familiar (C)
Toninato F.; Tàpies, JosepCase DG-1477StrategyEste caso complementa el caso (B): DG-1476.Starting at €5.74
-
The Captor Opportunity (C)
Valentí Vidal, Albert; González Rodríguez, Jorge; Reutskaja Pastushkova, Elena; Mendoza, ErnestCase M-1399-EMarketingCarbon Purity (CP) acquired Captor Materials S.L. (CM). The main asset of Captor Materials was a patented technology for the removal of nitrogen oxides (NOx). Accumulated exposure to NOx causes gradual health deterioration in employees exposed to these gases. The new Captor technology, which helps remove these NOx, is extremely valuable and can be implemented in a number of sectors where NOx are to be removed from gases. CP identified several mar...Starting at €5.74
-
Los Agnelli y el Grupo Fiat: La historia de un imperio familiar (A)
Toninato F.; Tàpies, JosepCase DG-1475StrategyEstos casos sintetizan los acontecimientos y encrucijadas más importantes en la historia de Fiat, una de las mayores empresas italianas, y tratan los problemas que los Agnelli tuvieron que afrontar para asegurar su control de la empresa en Italia, pese a varias crisis financieras y a problemas familiares trágicos. En particular, estos casos pueden usarse como reflejo de los típicos asuntos afrontados por los negocios de la familia propietaria; po...Starting at €8.20
-
Los Agnelli y el Grupo Fiat: La historia de un imperio familiar (B)
Toninato F.; Tàpies, JosepCase DG-1476StrategyComplementa el caso (A).Starting at €5.74
-
The Agnellis and the Fiat Group: The Story of a Family Empire (A)
Toninato F.; Tàpies, JosepCase DG-1475-EStrategyThese cases synthesize the most important events and turning points in the history of Fiat, one of the largest companies in Italy, and deal with the issues the Agnellis faced to secure their control of the company despite several financial crises and tragic family events. In particular, they can be used to reflect on the typical issues faced by family-owned businesses, such as how to manage the succession to new generations (in Fiat, there are n...Starting at €8.20
-
The Captor Opportunity (B)
Valentí Vidal, Albert; González Rodríguez, Jorge; Reutskaja Pastushkova, Elena; Mendoza, ErnestCase M-1398-EMarketingCarbon Purity (CP) acquired Captor Materials S.L. (CM). The main asset of Captor Materials was a patented technology for the removal of nitrogen oxides (NOx). Accumulated exposure to NOx causes gradual health deterioration in employees exposed to these gases. The new Captor technology, which helps remove these NOx, is extremely valuable and can be implemented in a number of sectors where NOx are to be removed from gases. CP identified several mar...Starting at €5.74
-
Laboratorio Benati: revitalizando la línea de medicamentos
Segarra, José Antonio; Valentí Vidal, AlbertCase M-1308Innovation and Change, Marketing, StrategyEn abril del 2013, Marco di Lucca, director general del Laboratorio Benati Italia estaba reunido con sus directores analizando el impacto de los últimos cambios legislativos en los resultados de la empresa. Benati era el laboratorio líder en Italia en el mercado dermatológico desde hacía más de una década y había alcanzado una gran reputación entre los consumidores, médicos y farmacéuticos. No obstante, en los últimos dos años los resultados de s...Starting at €8.20